{
  "challenge_uid": "65b4e2bb-864a-41ee-b15e-c8f9d7d410f5",
  "language": "en",
  "dialogues": [
    {
      "dialogue_uid": "129e5446-81c8-4023-9f23-169cac1bff82",
      "language": "en",
      "utterances": [
        "No, in your case, there're probably little dialogue.",
        "No dialogue.",
        "Visuals that are very clear and more or less fill up the screen.",
        "Yes.",
        "And easily readable.",
        "Easy to read.",
        "I guess not a great deal of character development.",
        "(Soundbite of laughter)",
        "Well, it's funny you say that because my editor did say don't forget, we're cutting for performance.",
        "(Soundbite of laughter)"
      ]
    },
    {
      "dialogue_uid": "3e40e774-b103-4822-8567-2b3620d85807",
      "language": "en",
      "utterances": [
        "Which you always want to do.",
        "So how do you cut for performance with a small dog, who has virtually no expressions on his face?",
        "There's not a lot character development.",
        "I was so skeptical of this idea, Renee.",
        "I was so terrified of it because I thought this is a part of a larger atomization of people, and that means no one gets together.",
        "And I really believe in cinema.",
        "But I have to say, it turned out to be so much fun.",
        "And I found that people share this material the same way they would if they were in a cinema.",
        "Well, the same way as in -",
        "They either gather around -",
        "Or they pass it around.",
        "Exactly.",
        "They either gather around and look at the phone, or they send it to each other.",
        "So that means that everyone is having this kind of collective experience.",
        "Though so separately.",
        "Though so separately.",
        "I mean it's a very strange and interesting shift in the transmission of ideas.",
        "And you can't go away from it and pretend it doesn't exist.",
        "When you read up on this new technology, there's now new words in the, that have entered the -",
        "The lexicon.",
        "The lexicon.",
        "Yeah like Siliwood and then Mobisodes.",
        "I'm gathering -"
      ]
    },
    {
      "dialogue_uid": "2fa68eb7-619b-4c45-894c-6b6c6b4fba39",
      "language": "en",
      "utterances": [
        "I've heard Mobisodes.",
        "Yes.",
        "Now, that one doesn't sound like it's going to fly.",
        "I hope not.",
        "Siliwood is funny though.",
        "I guess I'm for the Siliwood.",
        "(Soundbite of laughter)",
        "Thank you very much for joining us.",
        "Thank you.",
        "This was fun.",
        "The filmmaker Maria Maggenti.",
        "Her new big screen film, \"\"Puccini for Beginners,\"\" will be in theaters next month.",
        "(Soundbite of music)",
        "This is NPR News.",
        "This is ALL THINGS CONSIDERED from NPR News.",
        "I'm Michele Norris."
      ]
    },
    {
      "dialogue_uid": "827dc25a-34a1-4e42-94c8-c9734afe8497",
      "language": "en",
      "utterances": [
        "And I'm Melissa Block.",
        "Christmas.",
        "My guess would be Elizabeth Dole from North Carolina.",
        "Well, of course we don't know everything about what happened.",
        "When a data safety monitoring board stops a trial because of excess mortality, often the actual causes of death have not been adjudicated - haven't been looked at closely enough.",
        "And over the next several months, they'll be an opportunity to look more deeply into the data.",
        "In addition, there are other trials that have been going on in parallel.",
        "Now all research with this drug, torcetrapib, has been stopped.",
        "But I had already completed a study where we used tiny ultrasound probes to measure the buildup of plaque in the coronary arteries and to look at the effect of the drug on top of the statin drugs that have been so successful.",
        "Since that trial was completed - we were in the cleanup phase - and in early January we'll actually get a look at the data.",
        "This will be an important clue as to whether or not it is a class effect or whether something specific to Torcetrapib.",
        "We may find - and this may surprise you - but we may found that the drug was actually promoting the progression of atherosclerosis, of the plaque buildup in coronary arteries.",
        "And if that's the case, then its probably going to be the same problem with other drugs in the class, and we may have to look elsewhere at other ways to raise HDL that might benefit patients.",
        "And other drugs that might HDL.",
        "There are other ways to raise HDL.",
        "There are.",
        "We have some that are clinically available.",
        "One of them is the vitamin niacin.",
        "It can be taken in very large doses.",
        "It does work, although it doesn't produce as much HDL raising.",
        "What had us so excited about Torcetrapib is that we were seeing 50 percent increases in HDL.",
        "That's a really big increase.",
        "And if you look at that and you look at something like the Framingham Study - where we followed patients - a 50 percent increase in HDL would be an enormous decrease in the risk of heart attack and stroke if it actually was good HDLâ€¦",
        "Mm-hmm.",
        "Niacin, perhaps 20 or 25 percent increases.",
        "And the problem there is that there are certain number of patients that get flushing or itching of the skin, and so we just can't treat everybody with niacin.",
        "We don't get enough effect from it, and not everybody can take it."
      ]
    },
    {
      "dialogue_uid": "f993101e-e304-4d36-8d45-f1b85fdbcab1",
      "language": "en",
      "utterances": [
        "And I gather some drugs are in development that would reduce the flushing effect, which I gather drives people absolutely nuts.",
        "Well, you know, it's funny.",
        "You see people who just don't - aren't bothered by it.",
        "You know, they say, well, it's sort of a warm sensation, and they kind of get used to it, and after a period of time, they tolerate it very well.",
        "But side effects for drugs are very individualized.",
        "What will be OK for one person, would be just intolerable for the next person.",
        "So we have limits on what we can do with HDL, and that's why everybody was so excited about this.",
        "And obviously diet and exercise can affect your HDL as well.",
        "They can, although it's not as much as we would like.",
        "You know, first of all, everybody listening should understand that a proper diet and lots of exercise ought to be the mainstay for all of us.",
        "But you can only raise HDL five or 10 percent with these interventions.",
        "And, you know, if you're a patient who's HDL is really low, then we're going to need to have drugs to raise it if we want to be able to further reduce this terrible burden of disease.",
        "Let's see if we can get listeners in on the conversation.",
        "If you'd like to join us, our number is 800-989-8255, 800-989-TALK.",
        "Our e-mail address is talk@npr.org.",
        "And let's begin with John.",
        "John's with us from San Jose, California.",
        "Hi, thank you.",
        "I was watching CNBC when the Pfizer CEO was on when this news came out and was absolutely astounded to find out that over 80 people died during this trial.",
        "And my question is how many people would have died and they found it acceptable and brought the drug to market?",
        "What was the benchmark on deaths?",
        "It's just astounding that this would happen.",
        "So just interesting - would be interested to get your comments on that.",
        "Joanne Silberner, can you put that into context for us?",
        "I think I can put it into numbers context, and I think Dr. Nissen can put it into statistical context.",
        "The 82 people - it was 81, 82 people, 82 people out of a group of 7,500 people.",
        "In the other group there were 51 deaths, so it's not like 82 is from zero.",
        "It's 82 from 51, but I think for the statistical reasoning, let's ask Dr. Nissen.",
        "Well, doing a clinical trial is not easy, and the goal of course is to bring new medicines forward, and in doing that there are a number of ethical standards that have to be applied.",
        "And one of them is to have a group that's outside of the pharmaceutical company and outside of the trial investigators that's watching, and that's called a data safety and monitoring board.",
        "This one was chaired by a very experienced man who's done this for many years and who has - I have a lot of confidence in him.",
        "And so they're looking at the data and they know who got which drug.",
        "They know who got the sugar pill..."
      ]
    }
  ]
}